Getting latest data loading
X

Request a Call to Trade

In addition to the daily Research emails, I would also like to receive the Accendo Markets Weekly Newsletter and occasional Market Report emails highlighting various trading opportunities.
When you enter your telephone number, we may call or message you occasionally with trading opportunities. You can opt out at any time

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Upgrades/Downgrades - 14 March 2014

This page refreshes automatically every 30 mins. Press F5 to update manually

For a more detailed explanation of Upgrades/Downgrades see Link

Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained

Stock Broker Update
AstraZeneca JP Morgan downgrades to underweight from neutral; ups TP to 3,800p from 3,700p
Barclays Investec cuts TP to 295p from 305p, Buy
G4S Jefferies cuts TP to 280p from 290p, Buy
Hansteen Holdings Jefferies ups TP to 105p from 100p, Hold
Home Retail Citigroup ups TP to 215p from 205p, neutral
Home Retail Barclays ups TP to 150p from 140p, underweight
Hutchison China MediTech UBS downgrades to neutral from Buy; ups TP to 1000p from 820p
J Sainsbury Citigroup cuts TP to 350p from 425p, Buy
Mears Group Jefferies ups TP to 485p from 435p, Hold
Royal Dutch Shell SocGen ups TP to 2500p from 2400p, Hold
SIG Jefferies ups TP to 220p from 180p, Hold
Tesco Citigroup cuts TP to 300p from 320p, neutral
WM Morrison Supermarkets Citigroup cuts TP to 220p from 250p, neutral
Source: Reuters News, AlphaTerminal, Dow Jones Newswires

Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires

Back to Top

T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.